Healthcare Utilization Amongst Patients with NSCLC Before and After Testing with a Host Immune Classifier (HIC) in a Real-World Setting

被引：0
|
作者：
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.13
引用
收藏
页码：E13 / E14
页数：2
相关论文
共 50 条
  • [21] Real-world ALK Testing Trends and Patterns in Patients with Advanced NSCLC in the United States
    Lin, H.
    Wu, Y.
    Yin, Y.
    Niu, H.
    Humphries, M.
    Lovly, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S210 - S210
  • [22] Real-world Frequency of BRAF Testing and Utilization of Therapies in Patients with Advanced Melanoma
    Hill, M. V.
    Deng, M.
    Handorf, E.
    Olszanski, A. J.
    Farma, J. M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S108 - S108
  • [23] Real-world frequency of BRAF testing and utilization of therapies in patients with advanced melanoma
    Hill, Maureen, V
    Vidri, Roberto J.
    Deng, Mengying
    Handorf, Elizabeth
    Olszanski, Anthony J.
    Farma, Jeffrey M.
    MELANOMA RESEARCH, 2022, 32 (02) : 79 - 87
  • [24] CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER CONTINUING, SWITCHING, OR DISCONTINUING THERAPY IN A REAL-WORLD SETTING
    Lawrence, D.
    Touya, M.
    Wu, S. J.
    Teng, C. C.
    Wang, L.
    Chrones, L.
    Patel, S.
    Clayton, A.
    VALUE IN HEALTH, 2020, 23 : S204 - S204
  • [25] Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting
    Wayne Weng
    Ye Tian
    Sheldon X. Kong
    Rahul Ganguly
    Malene Hersloev
    Jason Brett
    Todd Hobbs
    Clinical Diabetes and Endocrinology, 6 (1):
  • [26] Real-World Healthcare Resource Utilization in Patients with Parkinson's Disease and Motor Fluctuations
    Serbin, M.
    Odak, S.
    Macahilig, C.
    Joshi, N.
    Shah, A.
    Ng, X.
    Olson, K.
    Liang, G.
    Klepitskaya, O.
    Yonan, C.
    MOVEMENT DISORDERS, 2020, 35 : S142 - S142
  • [27] Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia
    Connell, N. T.
    Caicedo, J.
    Nieto, N.
    Chatterjee, S.
    Hait, A.
    Gupta, A. K.
    Bullano, M.
    Schultz, B. G.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (06) : 691 - 699
  • [28] Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore
    Bayani, Diana Beatriz
    Lin, Yihao Clement
    Ooi, Melissa G.
    Tso, Allison Ching Yee
    Wee, Hwee Lin
    EJHAEM, 2023, 4 (04): : 1013 - 1018
  • [29] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [30] Demographics And Healthcare Utilization Of Patients With Idiopathic Pulmonary Fibrosis (ipf) In A Real-World Setting: Updated Findings From 277 Patients In The Proof Registry
    Wuyts, W. A.
    Dahlqvist, C.
    Slabbynk, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Joos, G. F.
    Maddens, S.
    Kolkman, E.
    Kirchgaessler, K. -U.
    Bartley, K.
    Bondue, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345